Abstract
The symptoms most commonly reported by patients affected by coronavirus disease (COVID-19) include cough, fever, and shortness of breath. However, other major events usually observed in COVID-19 patients (e.g., high blood pressure, arterial and venous thromboembolism, kidney disease, neurologic disorders, and diabetes mellitus) indicate that the virus is targeting the endothelium, one of the largest organs in the human body. Herein, we report a systematic and comprehensive evaluation of both clinical and preclinical evidence supporting the hypothesis that the endothelium is a key target organ in COVID-19, providing a mechanistic rationale behind its systemic manifestations.
Original language | English (US) |
---|---|
Article number | 1417 |
Journal | Journal of Clinical Medicine |
Volume | 9 |
Issue number | 5 |
DOIs | |
State | Published - May 2020 |
Keywords
- ACE2
- Acute kidney injury
- Blood pressure
- COVID
- Catepsin
- Coronavirus
- Cytokine storm
- Endothelium
- Heparin
- Kawasaki disease
ASJC Scopus subject areas
- Medicine(all)